Aller au contenu principal
Profil bibliographique

Nasimul Ahsan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

54Publications signalées
1800Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Renal Transplantation Outcomes and TreatmentsOrgan Donation and TransplantationPolyomavirus and related diseasesOrgan Transplantation Techniques and OutcomesRenal and Vascular Pathologies

Les publications récentes

2014 other OpenAlex

Basiliximab (Simulect®) and Daclizumab (Zenapax®)

Nadim Mahmud, C. Burcin Taner, Nasimul Ahsan

To function as effector cells, T cells must undergo antigen-stimulated activation that induces synthesis of many lymphokines, including interleukin-2 (IL-2). In certain diseases, a proportion of these stimulated cells will express surface interleukin-2 receptor (IL-2R) alpha peptide, and in these conditions the …

us (code pays fourni par la source)

1 citation
Accès ouvert 2012 article OpenAlex

Rituximab in immunologic glomerular diseases

Ahsan A. Ejaz, Abdo Asmar, Mourad M. Alsabbagh, Nasimul Ahsan

Experimental data suggest that the B-cell antigen CD20 may play a significant role in the pathogenesis of many diseases including glomerular diseases. These and other findings underpin the central concept of B-cell-depleting therapies that target CD20 antigen as treatments for lupus nephritis, …

us (code pays fourni par la source)

12 citations mAbs
Accès ouvert 2010 article OpenAlex

Antibody immunosuppressive therapy in solid-organ transplant

Nadim Mahmud, Dusko Klipa, Nasimul Ahsan

Currently, a wide variety of both polyclonal and monoclonal antibodies are being routinely utilized to prevent and treat solid organ rejection. More commonly, these agents are also administered in order to delay introduction of calcineurin inhibitors, especially in patients with already compromised …

us (code pays fourni par la source)

57 citations mAbs
2010 article OpenAlex

Immunosuppressive Therapies in Solid Organ Transplantation

Jaime Aranda‐Michel, Nasimul Ahsan

Background: Organ transplantation is a life saving procedure in patients with end-organ disease. While improvement in surgical techniques made transplantation possible in the 1960s, advances in immunosuppressive therapies have resulted in lower rates of acute cellular rejection and consequently, significant improvements in …

0 citations Immunology Endocrine & Metabolic Agents - Medicinal Chemistry
2009 article OpenAlex

Excellent Renal Allograft Survival in Donor-Specific Antibody Positive Transplant Patients—Role of Intravenous Immunoglobulin and Rabbit Antithymocyte Globulin

Nasimul Ahsan, Hani M. Wadei, Petrina V. Genco, Xochiquetzal J. Geiger et autres

BACKGROUND: Timely transplantation of sensitized kidney recipients remains a challenge. Patients with a complement-dependent cytotoxicity negative and flow cytometry (FC) positive crossmatch carry increased risk of antibody-mediated rejection and thus graft loss. Solid phase assays are available to confirm donor specificity for …

us (code pays fourni par la source)

38 citations Transplantation
2008 article OpenAlex

Steroid Avoidance: Is It Ready for Prime Time?

Nasimul Ahsan

One mark of success in organ transplantation is the attempt to reduce maintenance immunosuppression. This change in direction from maximizing therapy to exploring alternatives of minimizing drug treatment to prevent rejection is predicated on the success of current regimens to reduce rejection. …

us (code pays fourni par la source)

0 citations Transplantation

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.